Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria.
Pennisi G, Enea M, Romero-Gomez M, Bugianesi E, Wai-Sun Wong V, Fracanzani AL, de Ledinghen V, George J, Berzigotti A, Viganò M, Sebastiani G, Cannella R, Delamarre A, Di Maria G, Lange NF, Tulone A, Di Marco V, Cammà C, Petta S.
Pennisi G, et al. Among authors: fracanzani al.
Hepatology. 2024 Apr 1;79(4):912-925. doi: 10.1097/HEP.0000000000000616. Epub 2023 Oct 2.
Hepatology. 2024.
PMID: 37796137